What is Healionics?
Healionics is a clinical-stage biopharmaceutical company dedicated to addressing the critical need for enhanced bloodstream access in patients undergoing dialysis. The company's innovative approach aims to provide safer and more reliable means for dialysis, a vital procedure for individuals suffering from kidney failure. This focus positions Healionics within the significant and growing medical device and biotechnology sectors, where advancements in patient care and treatment efficacy are paramount.
How much funding has Healionics raised?
Healionics has raised a total of $10.3M across 3 funding rounds:
Debt
$150K
Other Financing Round
$4.7M
Private Equity
$5.5M
Debt (2020): $150K with participation from PPP
Other Financing Round (2021): $4.7M led by Keiretsu Forum
Private Equity (2024): $5.5M supported by Keiretsu Capital
Key Investors in Healionics
Keiretsu Capital
Keiretsu Capital LLC is an investment firm that provides opportunities through its extensive angel investor network, focusing on early-stage growth startups and technology companies. They offer various funds, including co-investment and real estate funds, and have over 20 years of experience in facilitating access to funding.
Keiretsu Forum
Keiretsu Forum is a global network of angel investors, venture capitalists, and corporate investors founded in 2000. Headquartered in San Francisco, California, the organization facilitates investment in early-stage companies and fosters collaboration among its members.
PPP
Public-Private Partnership
What's next for Healionics?
The recent major strategic investment in Healionics signals a pivotal moment for the company, likely enabling it to accelerate its clinical development pipeline and scale its operations. This substantial backing, part of its $10.4M in total capital, suggests strong investor confidence in Healionics' technology and its potential to disrupt the current standards of care for dialysis patients. The company is expected to leverage this financing to advance its product through further trials, regulatory approvals, and eventual market introduction, aiming to significantly improve patient outcomes and quality of life.
See full Healionics company page
